We observed that four subunits of OST showed a coordinated reduction in the inclusion of TRD from pre- to post-natal stages, which increased again in cancer patients in brain (Fig. 3e), with TUSC3 and RPN2 undergoing greatest change. The gene discussed is RPN2; the disease is cancer.